Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. No visible changes to study information or page layout.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page shows a revision update from v3.4.1 to v3.4.2, which appears to be a minor technical/version update with no changes to the study record or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.1 is now shown on the page, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

- Check48 days agoChange DetectedMinor metadata and UI updates: glossary shown by default and revision/QC fields updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0, while the older labels Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now shows Revision: v3.3.4, and the previous Revision: v3.3.3 tag has been removed. This is a minor administrative update to the version tag.SummaryDifference0.1%

- Check84 days agoChange DetectedThe Locations section now lists Michigan and New York under a single Locations heading, replacing the prior separate location blocks.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.